Infusense LLC, founded with a mission to revolutionize drug quantification, is a leading provider of comprehensive research and development services in engineering and life sciences. The company focuses on pioneering a biosensor platform that offers precise, rapid, and accessible sample analysis. Their innovative technology boasts exceptional detection limits and can perform thorough analyses in minutes, making laboratory capabilities portable and user-friendly.
Notable affiliated individuals and investors include experts in biosensor technology and life sciences, although specific names are not disclosed. Infusense has achieved significant milestones in developing their electrochemical modality, which has demonstrated the ability to detect analytes at sub-therapeutic levels. The overall impact of Infusense lies in its potential to transform drug monitoring and diagnostics, making advanced laboratory techniques more accessible and efficient.
